首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drugs in research & development

缩写:

ISSN:1174-5886

e-ISSN:1179-6901

IF/分区:2.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引608
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiang-Yang Xie,Yuan Zeng,Zhi-Long Chen et al. Xiang-Yang Xie et al.
Background and objective: Ketorolac tromethamine (KT), a nonsteroidal anti-inflammatory drug (NSAID) and cyclooxygenase inhibitor, is commonly used for the management of moderate to severe pain. The objective of this stud...
Long-Xun Zhu,Yong Chen,Xiang-Fan Chen et al. Long-Xun Zhu et al.
Background and objectives: Acute pancreatitis (AP) is a serious disease characterized by local inflammatory responses in the pancreas. The annual incidence rate of acute pancreatitis is 4.9-73.4 per 100,000 people. Among ...
Luca Bello,Pietro Riguzzi,Emilio Albamonte et al. Luca Bello et al.
The Italian Duchenne muscular dystrophy expert clinicians, gathered in the Italian Association of Myology (AIM), intend to express a position against the suspension of the Marketing Authorization of ataluren (Translarna®) for the treatment...
Sarah Walsh,Meaghan Bartlett,Elizabeth M Salvo-Halloran et al. Sarah Walsh et al.
Background and objectives: Several treatments for long-term prophylaxis (LTP) of hereditary angioedema (HAE) are in clinical use, such as garadacimab, lanadelumab, subcutaneous C1 esterase inhibitor (C1INH), and berotrals...
Derek E Murrell,Benjamin C Kennard,Maria E Bertoni et al. Derek E Murrell et al.
Background and objectives: The nucleoside reverse transcriptase inhibitors tenofovir alafenamide fumarate and tenofovir disoproxil fumarate are frequently employed in treating human immunodeficiency virus. Further, each f...
Sandra Ribes,Natalia Krivtsova,Celine Schelcher et al. Sandra Ribes et al.
Background and objectives: During the coronavirus disease-2019 (COVID-19) pandemic there was the uncertainty that the long-term immune response generated upon natural infection or triggered by available severe acute respi...
Liping Wei,Min Hong,Min Lu et al. Liping Wei et al.
Background & objectives: Contezolid (MRX-I) is a novel ortho-fluorophenyl dihydropyridone developed by MicuRx Pharmaceuticals, Inc. It has been approved for the treatment of drug-resistant Gram-positive bacterial infectio...
Min Wang,Yu Peng,Hegui Yan et al. Min Wang et al.
Background and objectives: Amisulpride is a second-generation antipsychotic drug that selectively binds to D2 and D3 dopaminergic receptors in the limbic system. In this study, the bioequivalence of an amisulpride formula...
Diamant Thaçi,Sascha Gerdes,Hendrik Schulze-Koops et al. Diamant Thaçi et al.
Background and objective: GP2015 is an etanercept biosimilar. Equivalent efficacy and comparable safety of GP2015 to reference etanercept (ref-ETN) was demonstrated in two phase III studies, one in patients with moderate-...
Xiaolin Xu,Xueting Mao,Bo Liu et al. Xiaolin Xu et al.
Background and objective: The purpose of this study is to investigate the status of blood concentration of sirolimus (SRL), explore the factors influencing SRL drug blood concentration, and provide guidance for the approp...